Article Versions Notes

Tourountzis T, Lioulios G, Stai S, Laecke SV, Moysidou E, Christodoulou M, Fouza A, Fylaktou A, Kantartzi K, Glorieux G, et al. Lymphocyte Phenotypes and Protein-Bound Uremic Toxins as Determinants of Clinical Outcomes in Hemodialysis Patients. International Journal of Molecular Sciences. 2025; 26(21):10376. https://doi.org/10.3390/ijms262110376

Tourountzis, Theodoros, Georgios Lioulios, Stamatia Stai, Steven Van Laecke, Eleni Moysidou, Michalis Christodoulou, Ariadni Fouza, Asimina Fylaktou, Konstantia Kantartzi, Griet Glorieux, and et al. 2025. "Lymphocyte Phenotypes and Protein-Bound Uremic Toxins as Determinants of Clinical Outcomes in Hemodialysis Patients" International Journal of Molecular Sciences 26, no. 21: 10376. https://doi.org/10.3390/ijms262110376

Tourountzis, T., Lioulios, G., Stai, S., Laecke, S. V., Moysidou, E., Christodoulou, M., Fouza, A., Fylaktou, A., Kantartzi, K., Glorieux, G., & Stangou, M. (2025). Lymphocyte Phenotypes and Protein-Bound Uremic Toxins as Determinants of Clinical Outcomes in Hemodialysis Patients. International Journal of Molecular Sciences, 26(21), 10376. https://doi.org/10.3390/ijms262110376